Follicular Lymphoma

• CLINICAL_TRIALS trial_result · 2010-12-30
  Clinical Trial Update: Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial evaluating Rituxan (rituximab) and chemotherapy followed by Zevalin (ibritumomab tiuxetan) for low-grade follicular non-Hodgki…

• CLINICAL_TRIALS trial_result · 2010-10-26
  Clinical Trial Update: A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma [Phase 2]

  A Phase 2 study of Velcade (bortezomib) in relapsed or refractory follicular lymphoma has been terminated.

• CLINICAL_TRIALS trial_result · 2010-10-18
  Clinical Trial Update: Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma [Phase 2]

  Phase 2 clinical trial evaluating immunochemotherapy, in vivo purging, peripheral blood stem cell mobilization, and autologous transplant in…

• CLINICAL_TRIALS trial_result · 2010-08-30
  Clinical Trial Update: Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Phase 2]

  A Phase 2 trial comparing rituximab plus sargramostim versus rituximab alone in relapsed follicular B-cell lymphoma (a form of non-Hodgkin l…

• CLINICAL_TRIALS trial_result · 2010-08-27
  Clinical Trial Update: Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial evaluating AT-101 in combination with Rituximab for previously untreated grade 1-2 follicular lymphoma, focusing on safety and…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2010-08-24
  Clinical Trial Update: A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

  This completed prospective observational study evaluated quality of life and costs in real-world patients treated with 90Y-Zevalin (ibritumo…

• CLINICAL_TRIALS trial_result · 2010-08-02
  Clinical Trial Update: Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma [Phase 3]

  A Phase 3 trial comparing Rituximab to Tositumomab with I-131 Tositumomab in relapsed follicular lymphoma has completed and posted results i…

• CLINICAL_TRIALS trial_result · 2010-05-17
  Clinical Trial Update: Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma [Phase 4]

  Phase 4 trial evaluating the efficacy duration and toxicity of Rituximab–Fludarabine–Cyclophosphamide as first-line therapy and Rituximab as…

• CLINICAL_TRIALS trial_result · 2010-01-29
  Clinical Trial Update: Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma [Phase 2]

  Phase 2 trial update of Dynavax's CpG 1018 adjuvant (1018 ISS) used after Rituxan in patients with B-cell follicular lymphoma; the study sta…

• CLINICAL_TRIALS trial_result · 2009-12-29
  Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma [Phase 1]

  This document notes the completion of a Phase 1 trial evaluating cellular adoptive immunotherapy in patients with relapsed or refractory fol…

• CLINICAL_TRIALS trial_result · 2009-03-12
  Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy [Phase 2]

  A Phase 2 trial assessing the efficacy and safety of Zevalin (ibritumomab tiuxetan) as a subsequent treatment in patients with follicular ly…

• CLINICAL_TRIALS trial_result · 2008-12-01
  Clinical Trial Update: Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy [Phase 3]

  Phase 3 trial comparing Zevalin (ibritumomab tiuxetan) versus no treatment as consolidation in follicular lymphoma patients who achieved par…

• CLINICAL_TRIALS trial_result · 2008-10-24
  Clinical Trial Update: High-Dose Therapy Treatment in Patients With Follicular Lymphoma [Phase 3]

  A Phase 3 trial evaluating high-dose therapy for follicular lymphoma has completed. The update does not include results.

• CLINICAL_TRIALS trial_result · 2008-05-29
  Clinical Trial Update: Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma [Phase 2]

  A Phase II trial evaluating CHOP-R followed by Zevalin and Rituxan in follicular lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2008-05-21
  Clinical Trial Update: Dietary Intervention in Follicular Lymphoma [Phase 2]

  Phase 2 trial evaluating a dietary intervention for follicular lymphoma; current status is unknown.

• CLINICAL_TRIALS trial_result · 2008-02-11
  Clinical Trial Update: VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma [Phase 2]

  Phase 2 study evaluating Velcade (bortezomib) in combination with rituximab for relapsed or refractory indolent B-cell lymphoma has complete…

• CLINICAL_TRIALS trial_result · 2007-11-14
  Clinical Trial Update: R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas [Phase 2]

  This is a completed Phase 2 clinical trial evaluating the R-MegaCHOP-ESHAP-BEAM regimen in high-risk aggressive B-cell lymphomas, including …

• CLINICAL_TRIALS trial_result · 2007-09-17
  Clinical Trial Update: Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab [Phase 1, Phase 2]

  This clinical trial update reports Phase 1/Phase 2 results for untreated or transformed follicular lymphoma treated with I-131 labeled tosit…

• CLINICAL_TRIALS trial_result · 2007-07-03
  Clinical Trial Update: Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden [Phase 3]

  A Phase 3 trial for newly diagnosed follicular lymphoma with a large tumor burden has completed.

• CLINICAL_TRIALS trial_result · 2006-10-26
  Clinical Trial Update: Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab [Phase 2]

  A Phase 2 clinical trial evaluating the safety and efficacy of fludarabine with cyclophosphamide and rituximab in Follicular lymphoma has co…